Article
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2024
Khushman Moh'd M, Toboni Michael D, Xiu Joanne, Manne Upender, Farrell Alex, Lou Emil, Shields Anthony F, Philip Philip A, Salem Mohamed E, Abraham Jim, Spetzler David, Marshall John, Jayachandran Priya, Hall Michael J, Lenz Heinz-Josef, Sahin Ibrahim Halil, Seeber Andreas, Powell Mathew A
Abstract excerpt
PURPOSE: The response to immune checkpoint inhibitors (ICI) in deficient mismatch repair (dMMR) colorectal cancer and endometrial cancer is variable. Here, we explored the differential response to ICIs according to different mismatch repair alterations. EXPERIMENTAL DESIGN: Colorectal cancer (N = 13,701) and endometrial cancer (N = 3,315) specimens were tested at Caris Life Sciences. Median overall survival (mOS)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
